Meet the expert...
Megan Baldwin
Founder and Chief Innovation Officer at Opthea

Dr. Megan Baldwin is the Founder and Chief Innovation Officer at Opthea, a dual-listed biotech company on the ASX and Nasdaq.
With over 20 years of experience in biotech, Dr. Baldwin has been instrumental in advancing innovative therapies for eye diseases, including Opthea’s lead asset, which aims to improve vision for patients with macular degeneration.